CDC Updates Interim PrEP Guidance to Include Injecting Drug Users

via CDC's Morbidity and Mortality Weekly Report

On June 12, 2013, the Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of human immunodeficiency virus (HIV) infection among injecting drug users (IDUs) (1). Based on these findings, CDC recommends that preexposure prophylaxis (PrEP) be considered as one of several prevention options for persons at very high risk for HIV acquisition through the injection of illicit drugs.

Read the rest.



 

Project Ready, Set, PrEP!'s Training Slides on PrEP for HIV Prevention

Chicago's Project Ready, Set, PrEP! (Project RSP!) has uploaded a fresh training on pre-exposure prophylaxis (PrEP) for HIV prevention. The training is designed for prevention workers, case managers, and others working in the HIV field and includes the key things you need to know about PrEP.

Check out the PowerPoint slides below, and feel free to download a copy. And please connect with us on Facebook. There are also a lot of helpful informational resources on the right-hand side of this blog just waiting to be clicked.

Project RSP! Training on PrEP for HIV Prevention